Navigation Links
BD Announces Results for Third Fiscal Quarter
Date:7/30/2009
247,083 252,944 ---------------------------------- ------- ------- NM - Not Meaningful (1) Total per share amounts may not add due to rounding BECTON DICKINSON AND COMPANY SUPPLEMENTAL INFORMATION (Unaudited; Amounts in thousands, except per share data) Nine Months ended June 30, 2009 ------------------------------------------------- As Litigation Tax Excluding Reported Charge (1) Adjustment(2) Items ---------- ----------- ------------ --------- Selling and administrative $1,272,318 $(45,000) $- $1,227,318 as a % of revenues 24.2% 23.3% Operating Income 1,210,745 45,000 - 1,255,745 as a % of revenues 23.0% 23.9% Income taxes 295,033 17,100 20,485 332,618 effective tax rate 24.5% 26.7% Income from continuing operations 907,297 27,900 (20,485) 914,712 as a % of revenues 17.2% 17.4% Diluted earnings per share -------------------------- Income from continuing operations $3.67 $0.11 $(0.08) $3.70 (1) Represents the charge relating to the pending settlement with the direct purchaser plaintiffs (which includes BD's distributors) in the antitrust class actions. (2) Represents the tax benefit relating to various tax settlements in multiple jurisdictions. BECTON DICKINSON AND COMPANY SUPPLEMENTAL REVENUE INFORMATION REVENUES BY SEGMENT AND GEOGRAPHIC AREA (Unaudit
'/>"/>
| SOURCE BD (Becton, Dickinson and Company) Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Prepaid Emergency Travel Announces a Unique Service That Provides Peace of Mind During Family Emergencies
2. The Mills Group LLC Announces ElderCare/PrimePlus Service
3. Tampa Bay Radiation Oncology Announces New Full Service Center at Bruce B Downs
4. Kensey Nash Corporation Announces its Fourth Quarter and Fiscal Year End 2009 Earnings Release Date and Teleconference
5. Roxane Laboratories, Inc. Announces the Launch of Risperidone Oral Solution 1mg/mL
6. ISTA Pharmaceuticals Announces Conference Call and Webcast of Second Quarter 2009 Financial Results
7. Akorn, Inc. Announces Second Quarter 2009 Earnings Release and Conference Call Information
8. Stryker Announces Election of New Director
9. Birdies for Breast Cancer Announces Fifth Annual Charity Golf Classic Hosted by Top Womens Golfer, Cristie Kerr
10. ASTRO announces 2009 Fellows
11. Smith & Nephew Announces Launch of ACTICOAT Flex Wound Care Products in the USA
Post Your Comments:
(Date:5/21/2013)... HealthDay Reporter , , MONDAY, May 20 (HealthDay News) ... drowsy run a higher risk of getting into car ... up on missed sleep on weekends puts them in ... "This is another challenge to adolescents that comes ... director and founder of the Center for Injury Research ...
(Date:5/21/2013)... of non-small cell lung cancer (NSCLC) in U.S. hospitals ... according to a new study., "In most patients, the ... is surgery," said researcher Jayanth Adusumalli, MBBS, of the ... study of more than 1,200,000 patients diagnosed with NSCLC ... we found statistically significant racial disparities in the surgical ...
(Date:5/21/2013)... an Alpha-1 proteinase inhibitor (A1-PI), a naturally occurring ... protects the lung,s elasticity, is effective in slowing ... antitrypsin deficiency (AATD), a life-threatening genetic disorder, according ... American Thoracic Society International Conference. , The study ... of lung tissue as measured by computed tomography ...
(Date:5/21/2013)... 2013 According to the Los ... to make possession of controlled substances (heroin, cocaine, crystal ... offense. MacGregor & Collins Orange County criminal lawyers believe ... overcrowding as well as improving rehabilitation rates amongst controlled ... bill met a great deal of resistance from the ...
(Date:5/21/2013)... 21, 2013 The first ever over-the-counter ... Seal, Anti Itchbalm, is ready to come to pharmacies ... and effective product which will help attract more customers ... community. , US Organic Group Corp. has developed Anti ... can be safely used on both adults and children, ...
Breaking Medicine News(10 mins):Health News:Weekend 'Catch-Up' Sleep May Cut Young Drivers' Crash Risk 2Health News:Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency 2Health News:Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency 3Health News:New Drug Bill to Lower Penalties for Possession of Controlled Substances Gains Support from Criminal Lawyers 2Health News:First Ever Over-the-Counter Organic Anti-Itch Ointment Developed by US Organic Group Corp. 2[0] Weekend 'Catch-Up' Sleep May Cut Young Drivers' Crash Risk[0] Racial disparities in the surgical management of non-small cell lung cancer[0] Treatment with A1-PI slows the progression of emphysema in Alpha-1 antitrypsin deficiency[0] New Drug Bill to Lower Penalties for Possession of Controlled Substances Gains Support from Criminal Lawyers[0] First Ever Over-the-Counter Organic Anti-Itch Ointment Developed by US Organic Group Corp.
... that craving a cigarette while performing a cognitive task ... wandering, but also makes that person less likely to ... The paper, titled "Out for a Smoke: The Impact ... the first evidence that craving disrupts an individual,s meta-awareness, ...
... , INDIANAPOLIS, Dec. 7 ... the availability of a smaller insulin vial, the first in the ... with diabetes being treated in a hospital. , The new smaller ... origin]) and Humulin® R-U100 (regular insulin human injection, ...
... , HORSHAM, Pa., Dec. 7 ... TEVA ), today announced the publication of four articles ... Journal of Allergy and Clinical Immunology (JACI), providing ... small airways in the understanding and treatment of asthma. This ...
... new University of Pittsburgh study reveals that craving a ... the chances of a person,s mind wandering, but also ... or her mind has wandered. The paper, titled ... on Zoning Out During Reading," provides the first evidence ...
... ... Hunt, a range of experts and healthcare leaders will focus on sharing best practices ... industries will discuss lessons learned in developing functional health information exchanges which provide safer ... ...
... who have been infected with West Nile virus may ... initial infection, potentially leading to kidney problems. The research, ... Journal of Infectious Diseases , is now available ... West Nile virus was first detected in the United ...
Cached Medicine News:Health News:Pitt study suggests craving hinders comprehension without your realizing it 2Health News:Lilly Announces the First 300-unit Vial of Insulin 2Health News:Lilly Announces the First 300-unit Vial of Insulin 3Health News:Lilly Announces the First 300-unit Vial of Insulin 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 2Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 3Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 4Health News:Data Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma Management 5Health News:Pitt study suggests craving hinders comprehension without you realizing it 2Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 2Health News:Orion Health Participates in International Forum to Break Down Barriers for Health Information Exchange 3Health News:West Nile virus infection may persist in kidneys years after initial infection 2Health News:West Nile virus infection may persist in kidneys years after initial infection 3Pitt study suggests craving hinders comprehension without your realizing itLilly Announces the First 300-unit Vial of InsulinData Published in Leading Respiratory Journal Reinforce Importance of Small Airways In Asthma ManagementPitt study suggests craving hinders comprehension without you realizing itOrion Health Participates in International Forum to Break Down Barriers for Health Information ExchangeWest Nile virus infection may persist in kidneys years after initial infection
(Date:5/21/2013)... May 21, 2013 Accuray Incorporated ... publication of study results involving hundreds of prostate ... System, the most widely used form of prostate ... 304 patients for a median of 5 years, ... that 97 percent of patients with low-risk and ...
(Date:5/21/2013)... ORLANDO, Fla. , May 21, 2013 /PRNewswire/ ... and safety results from the global Phase 3 ... protease inhibitor simeprevir (TMC435) led to sustained virologic ... (SVR12) in 79 percent of treatment-experienced genotype 1 ... disease, including all stages of liver fibrosis, when ...
(Date:5/21/2013)... 21, 2013 Abaxis, Inc. (NasdaqGS: ABAX), a ... today that Martin Mulroy , chief ... Dental & Veterinary Conference on Wednesday, May 29, 2013 ... at Le Parker Meridien Hotel in New ... Abaxis develops, manufactures, markets and sells portable blood ...
Breaking Medicine Technology:New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 2Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 3Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 4Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 5Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 6Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients 7Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference 2[0] New Data Validates CyberKnife SBRT for Prostate Cancer Treatment[0] Primary Efficacy and Safety Findings from Phase 3 Study of Janssen's Simeprevir Administered Once Daily Demonstrate Sustained Virologic Response in Treatment-Experienced Genotype 1 Chronic Hepatitis C Adult Patients[0] Abaxis, Inc. to Present at the Stifel Annual Dental & Veterinary Conference
... Results from the Phase II portion of a ... for the treatment of acute heart failure will be ... at the American College of Cardiology,s (ACC) 58th Annual ... of medicine, University of California San Francisco , ...
... Will Test Ability of Adecatumumab to Prolong Disease ... MetastasesBETHESDA, Md., March 23 Micromet, ... company developing novel, proprietary antibodies for the treatment ... the commencement of a randomized, controlled phase 2 ...
Cached Medicine Technology:Results From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session 2Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 2Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 3Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 4Micromet Has Started a New Phase 2 Trial with Adecatumumab in Colorectal Cancer Patients 5... is a state-of-the-art hair reduction and ... specially designed for use within a ... features and economy in a single ... treatment of unwanted hair, photo rejuvenation ...
... perfect mix of powerful, versatile, and innovative ... Palomar StarLux® Pulsed Light and Laser System.,With ... compact base unit so theres no ... treatments., You can choose among Laser, Intense ...
Perfect for physicians who prefer a Heavier and Longer tubing, permitting them maximum access around the OR table. 12 feet in length Sizes availabe to fit any vacuum canisters...
... Pump provides optimum flow rate ... Operates on any voltage worldwide. ... safety Interlock and easy load ... Double Spike Tubing, Dual Pneumatic ...
Medicine Products:| Copyright © 2003-2012 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |